SER 8-K 2026-10-09

Serina Therapeutics, Inc. (SER) 8-K dated 2026-10-09 — accession 0001708599-26-000060. This URL is the filing, not the SER hub.

Serina Therapeutics, Inc. (SER) is a biotechnology company listed on AMEX.

Serina Therapeutics, Inc. filed a 8-K on 2026-10-09. Accession 0001708599-26-000060.

Cached items: 5.03, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SER revenue for 2025-12-31 was $130.0K. Net income was -$19.2M. Revenue was down 8.5% from 2023-12-31 to 2025-12-31. SER currently screens at market cap $29.7M.

Not investment advice. The SER SEC hub lists recent forms. The stock page is the research view.